Genetic variants of estrogen beta and leptin receptors may cause gynecomastia in adolescent

Gene

Volumn 541, Issue 2, 2014, Pages 101-106

  Eren, Erdal ^a   Edgunlu, Tuba ^b   Korkmaz, Huseyin Anil ^c   Cakir, Esra Deniz Papatya ^d   Demir, Korcan ^e   Cetin, Esin Sakalli ^b   Celik, Sevim Karakas ^f  

^a HARRAN UNIVERSITY   (Turkey)

^b MUGLA SITKI KOCMAN UNIVERSITY   (Turkey)

^c Dr Behcet Uz Children's Teaching and Research Hospital   (Turkey)

^d Mersin Women's and Children's Hospital   (Turkey)

^e Gaziantep Children Hospital   (Turkey)

^f ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

Author keywords

Estrogen; Gynecomastia; Leptin; Polymorphism; Puberty

Indexed keywords

AROMATASE; DNA; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; LEPTIN; LEPTIN RECEPTOR; TESTOSTERONE;

ADOLESCENT; ADOLESCENT DISEASE; ARTICLE; BLOOD; CONTROLLED STUDY; DNA EXTRACTION; DNA POLYMORPHISM; ESTRADIOL BLOOD LEVEL; GENETIC VARIABILITY; GYNECOMASTIA; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TESTOSTERONE BLOOD LEVEL;

ESTROGEN; GYNECOMASTIA; LEPTIN; POLYMORPHISM; PUBERTY;

ADOLESCENT; AROMATASE; CASE-CONTROL STUDIES; CHILD; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GYNECOMASTIA; HAPLOTYPES; HUMANS; LEPTIN; MALE; POLYMORPHISM, GENETIC; PUBERTY; RECEPTORS, LEPTIN; TESTOSTERONE; TURKEY;

EID: 84897464008     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2014.03.013     Document Type: Article

References (42)

1. Andersen J., Orntoft T.F., Andersen J.A., Poulsen H.S. Gynecomastia. Immunohistochemical demonstration of estrogen receptors. Acta Pathologica, Microbiologica, et Immunologica Scandinavica. Section A 1987, 95:263-267.
2. Binai N.A., Carra G., Löwer J., Löwer R., Wessler S. Differential gene expression in ERα-positive and ERα-negative breast cancer cells upon leptin stimulation. Endocrine 2013, 44:496-503.
3. Binder G., et al. Dominant transmission of prepubertal gynecomastia due to serum estrone excess: hormonal, biochemical, and genetic analysis in a large kindred. The Journal of Clinical Endocrinology and Metabolism 2005, 90:484-492.
4. Braunstein G.D. Gynecomastia. The New England Journal of Medicine 1993, 328:490-495.
5. Braunstein G.D. Aromatase and gynecomastia. Endocrine-Related Cancer 1999, 6:315-324.
6. Bulard J., Mowszowicz I., Schaison G. Increased aromatase activity in pubic skin fibroblasts from patients with isolated gynecomastia. The Journal of Clinical Endocrinology and Metabolism 1987, 64:618-623.
7. Catalano S., et al. Leptin enhances, via AP-1, expression of aromatase in the MCF-7 cell line. The Journal of Biological Chemistry 2003, 278:28668-28676.
8. Catalano S., et al. Leptin induces, via ERK1/ERK2 signal, functional activation of estrogen receptor alpha in MCF-7 cells. The Journal of Biological Chemistry 2004, 279:19908-19915.
9. Cobellis L., et al. High plasma concentrations of di-(2-ethylhexyl)-phthalate in women with endometriosis. Human Reproduction (Oxford, England) 2003, 18:1512-1515.
10. Colon I., Caro D., Bourdony C.J., Rosario O. Identification of phthalate esters in the serum of young Puerto Rican girls with premature breast development. Environmental Health Perspectives 2000, 108:895-900.
11. Czajka-Oraniec I., Zgliczynski W., Puzianowska-Kuznicka M., Kurylowicz A., Mikula M., Ostrowski J. Role of c.454-351A/G polymorphism of estrogen receptor alpha gene in genetic predisposition to idiopathic gynecomastia. 5th Conference of the Section for Molecular Endocrinology of Polish Society of Endocrinology, 28-30 March 2007, Poznan, Poland 2007.
12. Czajka-Oraniec I., Zgliczynski W., Kurylowicz A., Mikula M., Ostrowski J. Association between gynecomastia and aromatase (CYP19) polymorphisms. European Journal of Endocrinology 2008, 158:721-727.
13. Dundar B., Dundar N., Erci T., Bober E., Büyükgebiz A. Leptin levels in boys with pubertal gynecomastia. Journal of Pediatric Endocrinology & Metabolism 2005, 18:929-934.
14. Durmaz E., et al. Plasma phthalate levels in pubertal gynecomastia. Pediatrics 2010, 125:e122-e129.
15. Ersöz H.ö, Onde M.E., Terekeci H., Kurtoglu S., Tor H. Causes of gynaecomastia in young adult males and factors associated with idiopathic gynaecomastia. International Journal of Andrology 2002, 25:312-316.
16. Garofalo C., et al. Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesity-related stimuli. Clinical Cancer Research 2006, 12:1447-1453.
17. Georgiadis E., et al. Incidence of gynecomastia in 954 young males and its relationship to somatometric parameters. Annals of Human Biology 1994, 21:579-587.
18. Glass A.R. Gynecomastia. Endocrinology and Metabolism Clinics of North America 1994, 23:825-837.
19. Henley D.V., Lipson N., Korach K.S., Bloch C.A. Prepubertal gynecomastia linked to lavender and tea tree oils. The New England Journal of Medicine 2007, 356:479-485.
20. Jin J.L., et al. Association between CYP19 gene SNP rs2414096 polymorphism and polycystic ovary syndrome in Chinese women. BMC Medical Genetics 2009, 10:139.
21. Joffe A. Gynecomastia. Adolescent Healthcare: A Practical Guide 2008, 180-184. Lippincott Williams & Wilkins, Philadelphia (PA). 5th ed. L.S. Neinstein, C.M. Gordon, D.K. Katzman, D.S. Rosen, E.R. Woods (Eds.).
22. Kitawaki J., Kusuki I., Koshiba H., Tsukamoto K., Honjo H. Leptin directly stimulates aromatase activity in human luteinized granulosa cells. Molecular Human Reproduction 1999, 5:708-713.
23. Kuczmarski R.J., et al. 2000 CDC growth charts for the United States: methods and development. National Center for Health Statistics. Vital and Health Statistics 2002, 11(246):1-190.
24. Kumanov P., Deepinder F., Robeva R., Tomova A., Li J., Agarwal A. Relationship of adolescent gynecomastia with varicocele and somatometric parameters: a cross-sectional study in 6200 healthy boys. The Journal of Adolescent Health 2007, 41:126-131.
25. Lee K.O., Chua D.Y., Cheah J.S. Oestrogen and progesterone receptors in men with bilateral or unilateral pubertal macromastia. Clinical Endocrinology 1990, 32:101-105.
26. Li X., et al. Mammary gland development in transgenic male mice expressing human P450 aromatase. Endocrinology 2002, 143:4074-4083.
27. Liu L., Wang L., Zheng J., Tang G. Leptin promotes human endometrial carcinoma cell proliferation by enhancing aromatase (P450arom) expression and estradiol formation. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2013, 170:198-201.
28. Machinal-Quélin F., Dieudonné M.N., Pecquery R., Leneveu M.C., Giudicelli Y. Direct in vitro effects of androgens and estrogens on ob gene expression and leptin secretion in human adipose tissue. Endocrine 2002, 18:179-184.
29. Mammès O., Betoulle D., Aubert R., Herbeth B., Siest G., Fumeron F. Association of the G-2548A polymorphism in the 5' region of the LEP gene with overweight. Annals of Human Genetics 2000, 64:391-394.
30. Matsuoka N., et al. Human leptin receptor gene in obese Japanese subjects: evidence against either obesity-causing mutations or association of sequence variants with obesity. Diabetologia 1997, 40:1204-1210.
31. Nicoletti G.F., et al. Differential expression of estrogen receptor α and β transcripts in tissues and in primary culture cells from pubertal gynecomastia. Journal of Endocrinological Investigation 2012, 35:150-153.
32. Niewoehner C.B., Nuttal F.Q. Gynecomastia in a hospitalized male population. The American Journal of Medicine 1984, 77:633-638.
33. Pensler J.M., et al. Estrogen and progesterone receptors in gynecomastia. Plastic and Reconstructive Surgery 2000, 106:1011-1013.
34. Poulsen H.S., Hermansen C., Andersen J.A., Andersen H.U., Jensen J. Gynecomasty: estrogen and androgen receptors. A clinical-pathological investigation. Acta Pathologica, Microbiologica, et Immunologica Scandinavica. Section A 1985, 93:229-233.
35. Qiao L., Zheng L., Cai D. Study on the di-n-butyl phthalate and di-2-ethylhexyl-phthalate level of girl serum related with precocious puberty in Shanghai. Wei Sheng Yan Jiu 2007, 36:93-95.
36. Safarinejad M.R., Safarinejad S., Shafiei N., Safarinejad S. Estrogen receptors alpha (rs2234693 and rs9340799), and beta (rs4986938 and rs1256049) genes polymorphism in prostate cancer: evidence for association with risk and histopathological tumor characteristics in Iranian men. Molecular Carcinogenesis 2012, 51:E104-E117.
37. Sasano H., Kimura M., Shizawa S., Kimura N., Nagura H. Aromatase and steroid receptors in gynecomastia and male breast carcinoma: an immunohistochemical study. The Journal of Clinical Endocrinology and Metabolism 1996, 81:3063-3067.
38. Schneider G., Kirschner M.A., Berkovitz R., Ertel N.H. Increased estrogen production in obese men. The Journal of Clinical Endocrinology and Metabolism 1979, 48:633-638.
39. Shozu M., et al. Estrogen excess associated with novel gain-of-function mutations affecting the aromatase gene. The New England Journal of Medicine 2003, 348:1855-1865.
40. Stratakis C.A., et al. The aromatase excess syndrome is associated with feminization of both sexes and autosomal dominant transmission of aberrant P450 aromatase gene transcription. The Journal of Clinical Endocrinology and Metabolism 1998, 83:1348-1357.
41. Stroheker T., Cabaton N., Nourdin G., Regnier J.F., Lhuguenot J.C., Chagnon M.C. Evaluation of anti-androgenic activity of di-(2-ethylhexyl)-phthalate. Toxicology 2005, 208:115-121.
42. Williams G. Aromatase up-regulation, insulin and raised intracellular oestrogens in men, induce adiposity, metabolic syndrome and prostate disease, via aberrant ER-α and GPER signalling. Molecular and Cellular Endocrinology 2012, 351:269-278.